RET-IN-23
RET-IN-23 is a potent and orally bioavailable small molecule inhibitor targeting RET, demonstrating significant anti-tumor efficacy in non-small cell lung cancer (NSCLC) models. It is a valuable research tool for investigating RET-driven oncogenesis in both in vitro cellular assays and in vivo xenograft studies.
Product Specifications
CAS Number
2479961-46-9
Field of Research
Cell Biology, Signal Transduction
Purity
97.46% (May vary between batches)
Smiles
FC=1C=NN (C1) C2=NC=C (C=C2) CN3C4CN (C5=NC=C (C=C5) C6=NC (=CC (=N6) C) NC7=NNC (=C7) C) CC3C4
Molecular Formula
C28H28FN11
Molecular Weight
537.59
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9945073 Inquire
Cavy V-Type Proton ATPase Subunit B, Brain Isoform (ATP6V1B2) ELISA Kit
Sign In for Pricing
View Details 
28496066 1.0 µg DNA
MGC114464 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
